A1	Arginase1
A1+/−	A1 heterozygous knockout
A2	Arginase 2
ABH	[2(S)-Amino-6-boronohexanoic acid], arginase inhibitor
AGE	Advanced glycation end products
BRECs	Bovine retinal endothelial cells
BSA	Bovine serum albumin
DAPI	4′,6′-diamino-2-phenylindole
ECs	Endothelial cells
FBS	Fetal bovine serum
HG	High glucose
HPRT	Hypoxanthine phosphoribosyl transferase
HUVECs	Human umbilical vein endothelial cells
Igfbp3	Insulin-like growth factor binding protein-3
MOI	Multiple of infections
NG	Normal glucose
NO	Nitric oxide
NOS	Nitric oxide synthase
NOX2	NADPH oxidase 2
OCT	Optimal cutting temperature
P16INK4a	cyclin-dependent kinase inhibitor 2A
P21	cyclin-dependent kinase inhibitor 1
P53	Tumor suppressor p53
PBS	Phosphate-buffered Saline
RFP	Red fluorescence protein
SA β-Gal	Senescence associated β-galactosidase
STZ	Streptozotocin
WT	Wild type
WT Ctrl	Wild type control
WT DB	Wild type diabetic
Δ A1	Inactive mutant arginase 1